# Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery

Study · id `cardio:ct-nct05708690` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05708690](<https://clinicaltrials.gov/study/NCT05708690>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05708690

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 132 participants.

## Technical summary

Registry record NCT05708690. Randomized; triple masking; primary purpose treatment. Start 2022-10-01 (actual); primary completion 2022-12-31 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 132 participants (enrolled count; ClinicalTrials.gov record NCT05708690, source copy `cardio:ctgov-nct05708690-2023-02-01`, retrieved 2026-10-26)
- Started: 2022-10-01 (actual) (ClinicalTrials.gov record NCT05708690, source copy `cardio:ctgov-nct05708690-2023-02-01`, retrieved 2026-10-26)
- Primary completion: 2022-12-31 (actual) (ClinicalTrials.gov record NCT05708690, source copy `cardio:ctgov-nct05708690-2023-02-01`, retrieved 2026-10-26)
- Completion: 2023-01-06 (actual) (ClinicalTrials.gov record NCT05708690, source copy `cardio:ctgov-nct05708690-2023-02-01`, retrieved 2026-10-26)
- Countries: Indonesia (ClinicalTrials.gov record NCT05708690, source copy `cardio:ctgov-nct05708690-2023-02-01`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05708690-2023-02-01`, retrieved 2026-10-26)

## The registry's words

- Brief title: Topical Effect of Tranexamic Acid in Postoperative Bleeding and Blood Products Transfusion After Cardiac Surgery
- Condition: Coronary Artery Disease
- Condition: Valvular Heart Disease
- Condition: Surgical Blood Loss
- Intervention (Drug): Tranexamic Acid 100 MG/ML
- Intervention (Drug): normal saline
- Lead sponsor: Universitas Indonesia
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Universitas Indonesia (`cardio:org-universitas-indonesia`)

## Provenance

Content hash: 3c602bb825477e0d8de49a5a77b7eb34a5c2e31a66195b0dba8abd8538d100c9
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
